36C77026Q0150 DROSPIRENONE- CHARLESTON

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL CMOP OFFICE (36C770)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C77026Q0150

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

NONE

Place of Performance

UNITED STATES

SourceSAM
Documents4
The Department of Veterans Affairs, through its National Consolidated Mail Outpatient Pharmacy (CMOP) Office, has issued Solicitation 36C77026Q0150 for the procurement of Drospirenone, a pharmaceutical product. This solicitation is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and carries the Product Service Code 6505, indicating a focus on drugs and biologicals. The procurement is not subject to any set-aside restrictions, making it open to all qualified vendors. The primary objective of this procurement is to secure a reliable supply of Drospirenone for distribution through the Charleston CMOP facility, supporting the ongoing pharmaceutical needs of veterans served by the Department of Veterans Affairs. The scope of the contract likely includes the manufacturing, packaging, and timely delivery of Drospirenone in accordance with federal standards and VA-specific requirements, although detailed specifications and quantities are provided in the attached solicitation documents referenced in the notice. The intended outcome is to ensure uninterrupted access to this essential medication for VA beneficiaries, maintaining high standards of quality, safety, and regulatory compliance throughout the contract period. Contractors are expected to demonstrate robust capabilities in pharmaceutical manufacturing, quality assurance, and distribution logistics within the United States. The contracting activity is managed by the National CMOP Office (organization key: 100183245), a federal office within the Department of Veterans Affairs. The place of performance is within the United States, with specific operations likely centered around the Charleston facility. Interested vendors should note that the solicitation is currently active, with a response deadline of July 6, 2026, at 22:07. All inquiries and submissions should be directed to the primary point of contact, Kayla Powers, who can be reached via email at [email protected] or by phone at 913-758-9915. Contractors considering this opportunity should review the four attachments available on the official SAM.gov notice page (https://sam.gov/opp/d392a5c701e84f99a9105071a36e518f/view) for comprehensive requirements, submission instructions, and evaluation criteria. This procurement represents a significant opportunity for qualified pharmaceutical manufacturers to support the VA’s mission of providing high-quality healthcare to veterans nationwide.